OHR PHARMACEUTICAL
OHR Pharmaceutical is a development-stage biotechnology company that focuses on the development of products for the treatment of cancer cachexia (multi-symptom wasting disorder) and wet- age-related macular degeneration. It was founded in 2009 and is headquartered in New York, New York.
OHR PHARMACEUTICAL
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2009-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.ohrpharmaceutical.com
Total Employee:
1+
Status:
Active
Contact:
(212) 682-8452
Email Addresses:
[email protected]
Total Funding:
47.92 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Domain Not Resolving Google Maps GoDaddy DNS Google Google Cloud OpenResty Google Adsense
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
IVERIC bio
IVERIC bio is a biopharmaceutical company developing novel therapies for age-related macular degeneration.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2019-01-03 | NeuBase Therapeutics | NeuBase Therapeutics acquired by OHR Pharmaceutical | N/A |
Official Site Inspections
http://www.ohrpharmaceutical.com
- Host name: 131.153.148.59
- IP address: 131.153.148.59
- Location: Tempe United States
- Latitude: 33.4306
- Longitude: -111.9256
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85281
More informations about "OHR Pharmaceutical"
OHR Pharmaceutical - Crunchbase Company Profile
Contact Email [email protected] Phone Number (212) 682-8452 OHR Pharmaceutical is a development-stage biotechnology company that …See details»
Ohr Pharmaceutical Company Profile 2025: Valuation, …
Ohr Pharmaceutical General Information Description. Ohr Pharmaceutical Inc is a US-based pharmaceutical company which focuses on the development of novel therapeutics and delivery technologies for the treatment of ocular disease.See details»
Ohr Pharmaceutical - Company Profile - Tracxn
Website: ohrpharmaceutical.com; Social: Key Metrics. Latest Funding Round. Post IPO, Dec 29, 2014, $50K. Ranked. 604 th among 2100 active competitors. Similar Companies. Avidity …See details»
Ohr Pharmaceutical, Inc.:Company Profile & Technical Research ...
Ohr Pharmaceutical, Inc. is a company that provides Cachexia, Macular degeneration, Clinical trial and more. Ohr Pharmaceutical, Inc. is headquartered in United States New York.See details»
OHR Pharmaceutical | VentureRadar
OHR Pharmaceutical VentureRadar profile. Find out more about OHR Pharmaceutical, Small Molecules.See details»
www.ohrpharmaceutical.com
Www.ohrpharmaceutical.comSee details»
Governance OHR Pharmaceutical Inc Nasdaq - MarketScreener.com
Jul 11, 2019 Director/Board Member 2022-10-13 2024-01-15See details»
Ohr Pharmaceutical, Inc. - Drug pipelines, Patents, Clinical
Ohrpharmaceutical.com. Public Company | 2009 | New York, United States | < 10 | NASDAQ: OHRP | ohrpharmaceutical.com. Last update 01 Nov 2024. Overview. Pipeline. Deal. ... The …See details»
Ohr Pharmaceutical Company Profile | Management and
Find contact information for Ohr Pharmaceutical. Learn about their Manufacturing market share, competitors, and Ohr Pharmaceutical's email format.See details»
Company OHR Pharmaceutical Inc Nasdaq - MarketScreener.com
Oct 13, 2022 OHR Pharmaceutical Inc: Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Nasdaq: | NasdaqSee details»
Ohr Pharmaceutical Inc Management Team | Org Chart
Ohr Pharmaceutical Inc employs 3 employees. The Ohr Pharmaceutical Inc management team includes Jason Slakter (CEO), and Nicholas Martin (Senior Research Associate). Get Contact …See details»
Ohr Pharmaceutical Inc - Company Info, Employees & Competitors
View Ohr pharmaceutical inc ohrpharmaceutical.com location in 350 technology dr, pittsburgh, pennsylvania, 15219, revenue, industry and description. Find related and similar companies as …See details»
Ohr Pharmaceuticals - Overview, News & Similar companies
View Ohr Pharmaceuticals (www.ohrpharmaceutical.net) location in New York, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
Ohr Pharmaceutical Inc: Contact Details and Business Profile
Ohr Pharmaceutical, Inc. (OHRP) is a clinical-stage pharmaceutical company developing novel therapies for ophthalmic diseases. The company has completed two clinical trials with …See details»
Ohr Pharmaceutical’s Competitors, Revenue, Number of ... - Owler
Ohr Pharmaceutical’s Profile, Revenue and Employees. OHR Pharmaceutical develops novel pharmaceuticals treatment for ophthalmology. Ohr Pharmaceutical’s primary competitors …See details»
Ohr Pharmaceutical Inc. - BioCentury Company Profiles - BCIQ
Aug 1, 2019 Ohr Pharmaceutical Inc. - BioCentury Company Profiles for the biopharma industrySee details»
Ohr Pharmaceutical, Inc. (Ohr Pharmaceutical, Inc.) - 药物管线_专 …
The immunomodulator OHR/AVR118 has been shown to increase IL-8 and MCP-1 secretion from non-activated human monocytes and U937 pro-monocytic cells, but to decrease MCP-1 …See details»
Ohr Pharmaceutical Inc Contracts & Agreements - Justia
May 29, 2024 OHRPHARMACEUTICAL INC. STOCKOPTION AGREEMENT (Filed With SEC on March 15, 2012) EMPLOYMENTAGREEMENT (Filed With SEC on March 15, 2012) Form …See details»
OHR Pharmaceutical (OHRP) Stock Price, News & Analysis
3 days ago OHR Pharmaceutical shares reverse split on Monday, February 4th 2019. The 1-20 reverse split was announced on Wednesday, January 23rd 2019. The number of shares …See details»
Ohr Pharmaceutical Inc Email Format | ohrpharmaceutical.com …
The most common Ohr Pharmaceutical Inc email format is [first_initial][last] (ex. [email protected]), which is being used by 75.0% of Ohr Pharmaceutical Inc work …See details»